Cambridge Advisors’s Cambria Cannabis ETF TOKE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,495
Closed -$130K 170
2023
Q2
$130K Buy
22,495
+269
+1% +$1.61K 0.03% 166
2023
Q1
$139K Sell
22,226
-550
-2% -$3.71K 0.04% 179
2022
Q4
$152K Sell
22,776
-2,352
-9% -$16.9K 0.04% 179
2022
Q3
$164K Sell
25,128
-1,928
-7% -$15.2K 0.05% 169
2022
Q2
$219K Sell
27,056
-3,881
-13% -$37.1K 0.06% 164
2022
Q1
$358K Sell
30,937
-32
-0.1% -$368 0.09% 138
2021
Q4
$385K Sell
30,969
-1,722
-5% -$22.9K 0.09% 138
2021
Q3
$460K Buy
32,691
+508
+2% +$7.98K 0.11% 123
2021
Q2
$583K Buy
32,183
+1,753
+6% +$32.3K 0.14% 103
2021
Q1
$623K Buy
30,430
+300
+1% +$6.04K 0.16% 92
2020
Q4
$441K Sell
30,130
-59
-0.2% -$785 0.12% 104
2020
Q3
$330K Buy
30,189
+6,903
+30% +$84.4K 0.1% 119
2020
Q2
$286K Buy
23,286
+393
+2% +$4.62K 0.09% 119
2020
Q1
$237K Buy
22,893
+7,990
+54% +$105K 0.09% 124
2019
Q4
$227K Buy
+14,903
New +$245K 0.07% 134

Other funds holding TOKE

Cambridge Advisors's TOKE Position: Q3 2023 in Review

Cambridge Advisors sold out of Cambria Cannabis ETF (TOKE) in Q3 2023, closing a stake of 22,495 shares — an estimated $130K sold.

Cambridge Advisors first reported a position in TOKE in Q4 2019 and held it in 15 quarters. The position peaked at $623K in Q1 2021. 19 funds tracked by Wall St. Rank hold TOKE as of Q3 2023.

  • Cambridge Advisors reported no remaining Cambria Cannabis ETF position as of Q3 2023 after selling out during the quarter.
  • Cambridge Advisors sold 22,495 Cambria Cannabis ETF shares in Q3 2023, an estimated $130K.
  • Cambridge Advisors first reported a position in Cambria Cannabis ETF in Q4 2019 and held it in 15 quarters.
  • Cambridge Advisors's Cambria Cannabis ETF position peaked at $623K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q3 2023.

Based on Cambridge Advisors's 13F filing for Q3 2023, filed 18 Oct 2023.